Lysine methyltransferase G9a is required for de novo DNA methylation and the establishment, but not the maintenance, of proviral silencing

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 14, 2011, Pages 5718-5723

  Leung, Danny C ^a   Dong, Kevin B ^a   Maksakova, Irina A ^a,b   Goyal, Preeti ^a   Appanah, Ruth ^a   Lee, Sandra ^a   Tachibana, Makoto ^c   Shinkai, Yoichi ^c   Lehnertz, Bernhard ^a   Mager, Dixie L ^b   Rossi, Fabio ^a   Lorincz, Matthew C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Covalent histone modification; Epigenetics; Long terminal repeat

Indexed keywords

DNA; HISTONE LYSINE METHYLTRANSFERASE; LYSINE METHYLTRANSFERASE G9A; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; CONFERENCE PAPER; CONTROLLED STUDY; DNA METHYLATION; EMBRYONIC STEM CELL; ENDOGENOUS RETROVIRUS; GENE SILENCING; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVIRUS;

MOLONEY MURINE LEUKEMIA VIRUS; MURINAE;

EID: 79955042533     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1014660108     Document Type: Article

References (50)

1. Ellis J (2005) Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum Gene Ther 16:1241-1246. (Pubitemid 41611651)
2. Harris RS, Liddament MT (2004) Retroviral restriction by APOBEC proteins. Nat Rev Immunol 4:868-877. (Pubitemid 39490762)
3. Dranoff G, et al. (1993) Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 90:3539-3543. (Pubitemid 23111402)
4. Bestor TH (2000) Gene silencing as a threat to the success of gene therapy. J Clin Invest 105:409-411. (Pubitemid 30127239)
5. Flanagan JR, Krieg AM, Max EE, Khan AS (1989) Negative control region at the 5′ end of murine leukemia virus long terminal repeats. Mol Cell Biol 9:739-746. (Pubitemid 19038874)
6. Tsukiyama T, Niwa O, Yokoro K (1989) Mechanism of suppression of the long terminal repeat of Moloney leukemia virus in mouse embryonal carcinoma cells. Mol Cell Biol 9:4670-4676. (Pubitemid 19275933)
7. Pannell D, et al. (2000) Retrovirus vector silencing is de novo methylase- independent and marked by a repressive histone code. EMBO J 19:5884-5894.
8. Yao S, et al. (2004) Retrovirus silencing, variegation, extinction, and memory are controlled by a dynamic interplay of multiple epigenetic modifications. Mol Ther 10: 27-36. (Pubitemid 38878146)
9. Changolkar LN, Singh G, Pehrson JR (2008) macroH2A1-dependent silencing of endogenous murine leukemia viruses. Mol Cell Biol 28:2059-2065. (Pubitemid 351342635)
10. Jähner D, et al. (1982) De novo methylation and expression of retroviral genomes during mouse embryogenesis. Nature 298:623-628. (Pubitemid 12099716)
11. Colicelli J, Goff SP (1986) Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. J Virol 57:37-45. (Pubitemid 16147915)
12. Barklis E, Mulligan RC, Jaenisch R (1986) Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells. Cell 47:391-399. (Pubitemid 17210153)
13. Petersen R, Kempler G, Barklis E (1991) A stem cell-specific silencer in the primerbinding site of a retrovirus. Mol Cell Biol 11:1214-1221. (Pubitemid 21895477)
14. Wolf D, Goff SP (2007) TRIM28 mediates primer binding site-targeted silencing of murine leukemia virus in embryonic cells. Cell 131:46-57. (Pubitemid 47498526)
15. Wolf D, Goff SP (2009) Embryonic stem cells use ZFP809 to silence retroviral DNAs. Nature 458:1201-1204.
16. Grez M, Akgün E, Hilberg F, Ostertag W (1990) Embryonic stem cell virus, a recombinant murine retrovirus with expression in embryonic stem cells. Proc Natl Acad Sci USA 87:9202-9206. (Pubitemid 120030593)
17. Challita PM, et al. (1995) Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells. J Virol 69:748-755.
18. Hawley RG, Lieu FH, Fong AZ, Hawley TS (1994) Versatile retroviral vectors for potential use in gene therapy. Gene Ther 1:136-138.
19. Cherry SR, Biniszkiewicz D, van Parijs L, Baltimore D, Jaenisch R (2000) Retroviral expression in embryonic stem cells and hematopoietic stem cells. Mol Cell Biol 20: 7419-7426.
20. Niwa O, Yokota Y, Ishida H, Sugahara T (1983) Independent mechanisms involved in suppression of the Moloney leukemia virus genome during differentiation of murine teratocarcinoma cells. Cell 32:1105-1113. (Pubitemid 13033049)
21. Stewart CL, Stuhlmann H, Jähner D, Jaenisch R (1982) De novo methylation, expression, and infectivity of retroviral genomes introduced into embryonal carcinoma cells. Proc Natl Acad Sci USA 79:4098-4102. (Pubitemid 12035085)
22. Lorincz MC, Schübeler D, Groudine M (2001) Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation. Mol Cell Biol 21:7913-7922. (Pubitemid 33051784)
23. Gautsch JW, Wilson MC (1983) Delayed de novo methylation in teratocarcinoma suggests additional tissue-specific mechanisms for controlling gene expression. Nature 301:32-37. (Pubitemid 13154458)
24. Mikkelsen TS, et al. (2007) Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448:553-560. (Pubitemid 47206934)
25. Martens JH, et al. (2005) The profile of repeat-associated histone lysine methylation states in the mouse epigenome. EMBO J 24:800-812. (Pubitemid 40396109)
26. Peters AH, et al. (2003) Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol Cell 12:1577-1589. (Pubitemid 38037024)
27. Dong KB, et al. (2008) DNA methylation in ES cells requires the lysine methyltransferase G9a but not its catalytic activity. EMBO J 27:2691-2701.
28. Matsui T, et al. (2010) Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET. Nature 464:927-931.
29. Tachibana M, et al. (2002) G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev 16:1779-1791. (Pubitemid 34803894)
30. Swindle CS, Kim HG, Klug CA (2004) Mutation of CpGs in the murine stem cell virus retroviral vector long terminal repeat represses silencing in embryonic stem cells. J Biol Chem 279:34-41. (Pubitemid 38044796)
31. Tachibana M, Matsumura Y, Fukuda M, Kimura H, Shinkai Y (2008) G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription. EMBO J 27:2681-2690.
32. Okano M, Bell DW, Haber DA, Li E (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99: 247-257. (Pubitemid 29519904)
33. Lei H, et al. (1996) De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development 122:3195-3205.
34. Chen T, Ueda Y, Xie S, Li E (2002) A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with active de novo methylation. J Biol Chem 277:38746-38754. (Pubitemid 35154737)
35. Lehnertz B, et al. (2003) Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 13:1192-1200. (Pubitemid 36872941)
36. Lachner M, O'Carroll D, Rea S, Mechtler K, Jenuwein T (2001) Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410:116-120. (Pubitemid 32225847)
37. Appanah R, Dickerson DR, Goyal P, Groudine M, Lorincz MC (2007) An unmethylated 3′ promoter-proximal region is required for efficient transcription initiation. PLoS Genet 3:e27.
38. Vakoc CR, Mandat SA, Olenchock BA, Blobel GA (2005) Histone H3 lysine 9 methylation and HP1γ are associated with transcription elongation through mammalian chromatin. Mol Cell 19:381-391. (Pubitemid 41074893)
39. Tachibana M, Nozaki M, Takeda N, Shinkai Y (2007) Functional dynamics of H3K9 methylation during meiotic prophase progression. EMBO J 26:3346-3359. (Pubitemid 47123532)
40. Dodge JE, et al. (2005) Inactivation of Dnmt3b in mouse embryonic fibroblasts results in DNA hypomethylation, chromosomal instability, and spontaneous immortalization. J Biol Chem 280:17986-17991.
41. Zhu H, et al. (2006) Lsh is involved in de novo methylation of DNA. EMBO J 25: 335-345. (Pubitemid 43152854)
42. Freitag M, Selker EU (2005) Controlling DNA methylation: Many roads to one modification. Curr Opin Genet Dev 15:191-199. (Pubitemid 40410665)
43. Thomas CE, Ehrhardt A, Kay MA (2003) Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 4:346-358. (Pubitemid 36538359)
44. Wu X, Li Y, Crise B, Burgess SM (2003) Transcription start regions in the human genome are favored targets for MLV integration. Science 300:1749-1751. (Pubitemid 36712571)
45. Sharif J, et al. (2007) The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 450:908-912. (Pubitemid 350231331)
46. Estève PO, et al. (2006) Direct interaction between DNMT1 and G9a coordinates DNA and histone methylation during replication. Genes Dev 20:3089-3103.
47. Ooi SK, et al. (2010) Dynamic instability of genomic methylation patterns in pluripotent stem cells. Epigenetics Chromatin 3:17.
48. Nimura K, et al. (2006) Dnmt3a2 targets endogenous Dnmt3L to ES cell chromatin and induces regional DNA methylation. Genes Cells 11:1225-1237. (Pubitemid 44426210)
49. Jackson-Grusby L, et al. (2001) Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet 27:31-39. (Pubitemid 32044515)
50. Myant K, et al. (2011) LSH and G9a/GLP complex are required for developmentally programmed DNA methylation. Genome Res 21:83-94.